Body Image and Physical Activity of Women with Breast Cancer

NCT ID: NCT06730815

Last Updated: 2024-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this self-initiated questionnaire-based follow-up clinical trial is to map the body image and physical activity of Hungarian women treated for breast cancer.

The main questions it aims to answer are:

1. How body image changes during different treatments among women treated for breast cancer?
2. How is physical activity among Hungarian women treated for breast cancer?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of our research is to assess the changes in physical activity and body image of women with breast cancer and the impact of these changes on their quality of life using subjective measures, through cross-sectional research and validation of the Body Image After Breast Cancer questionnaire in Hungarian.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Female Physical Inactivity Quality of Life Body Image

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

body image after breast cancer physical activity life quality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hungarian women treated for breast cancer

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult women diagnosis of breast carcinoma

Exclusion Criteria

* neuromuscular diseases
* severe congenital musculoskeletal and other disorders
* other surgical procedures within 1 year
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pecs

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vörösmarty utca 4.

Pécs, Baranya, Hungary

Site Status RECRUITING

Édesanyák útja 17.

Pécs, Baranya, Hungary

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Hungary

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Márta Hock, physiotherapist

Role: CONTACT

Phone: +3672501500

Email: [email protected]

Zsuzsanna Poto, economist

Role: CONTACT

Phone: +36205019991

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Márta Hock, physiotherapist

Role: primary

Márta Hock, physiotherapist

Role: backup

Erika Kövér, physician

Role: primary

Erika Kövér, physician

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9533-PTE 2023.

Identifier Type: -

Identifier Source: org_study_id